Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftment
- PMID: 37664464
- PMCID: PMC10471974
- DOI: 10.3389/fcell.2023.1265005
Corrigendum: Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftment
Abstract
[This corrects the article DOI: 10.3389/fcell.2021.624601.].
Keywords: Wharton’s jelly; cardiac fibrosis; cell therapy; donor variability; mesenchymal stromal (or stem) cells; myocardial infarction; regeneration/repair; umbilical cord matrix derived mesenchymal stromal cells (hUCM-MSCs).
Copyright © 2023 Laundos, Vasques-Nóvoa, Gomes, Sampaio-Pinto, Cruz, Cruz, Santos, Barcia, Pinto-do-Ó and Nascimento.
Erratum for
-
Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient Engraftment.Front Cell Dev Biol. 2021 Feb 4;9:624601. doi: 10.3389/fcell.2021.624601. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33614654 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
